InvestorsHub Logo
Followers 800
Posts 50868
Boards Moderated 2
Alias Born 12/12/2004

Re: None

Monday, 04/04/2022 1:32:35 PM

Monday, April 04, 2022 1:32:35 PM

Post# of 126
NLTX moving up before ACCR > Neoleukin Therapeutics, Inc., "Neoleukin" (NASDAQ:NLTX), a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, today announced three presentations at the upcoming American Association for Cancer Research (AACR) Annual Meeting taking place April 8-13, 2022 in New Orleans, Louisiana.

New York Yankees and Duke Basketball

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NLTX News